MMS Holdings Launches New Time-Saving Application to Automatically Perform Quality Control and Style Checks for Medical Writers
Automatiqc®, an AI tool designed to improve quality and bring efficiencies to the medical and regulatory writing process
Automatiqc®
Automatiqc® is a cloud-based solution that utilizes robotic process automation (RPA), a form of artificial intelligence (AI), to apply the necessary document formatting and style conventions. This frees up writers to focus on the key messaging, stakeholder alignment, and other key elements that are most critical to the medical and regulatory writing process.
Demonstrated time savings have provided sponsors up to one-third (33 percent) of time back in the quality process, with efficiencies across several roles.
Additional key benefits of Automatiqc® include:
- Removes the burden of style and formatting from the regulatory or medical writer, saving time for critical data elements
- Built-in set of rules that can be customized to meet any internal company or external audience document style requirements
- Compounding efficiencies with document amendments, improving the quality of documents and elimination of the review and QC steps in subsequent drafts or document amendments
- Complementary and compatible with other tools including PleaseReview, Veeva RIM, and many others
- Easy output provided in tracked changes for greater visibility to the writer
With this innovative medical writing technology, Automatiqc® users are now able to focus where they can bring the greatest value – to the science of Medical & Regulatory Writing.
Fill out the form at right to request a demo of Automatiqc®
Find out more about our commitment to innovation and tech-enablement here
Authoring Efficiencies Webinar
EXPERT INSIGHTS
Medical writing experts discuss recent technological advancements, writing efficiencies, and a top-to-bottom integration approach across key stakeholders to produce high-quality CSRs that are FDA/EMA submission- and clinical trial disclosure-ready.
Request a demo of Automatiqc®
Suggested For You
news
December 8th, 2021
MMS Holdings Wins 2021 Scrip Award for Best Contract Research Organization
news
October 28th, 2021
Praxis bioresearch seeks support from MMS for Alzheimers Disease Therapeutics
news
September 22nd, 2021
MMS SmartStart™ Tech-Enabled Solution Eases Document Content Creation Process
news
October 28th, 2020
MMS Academy Launches Mobile App for Accessing Pharmaceutical Industry Virtual Learning Courses from Anywhere
news
August 18th, 2020
MMS Academy Partners with MPGI in India
news
October 10th, 2019
MMS Holdings Announces Status As A Finalist For Best Contract Research Organization
news
March 13th, 2019
GHP Recognises MMS Holdings in the 2019 Biotechnology Awards Winners
news
August 23rd, 2018
MMS Wins Best Global Biotech CRO in the International Life Sciences Awards 2018
news
May 1st, 2018
MMS Partners with University of Findlay to Provide Medical Writing and Clinical Trial Disclosure Courses
news
November 15th, 2017
MMS Selected by Paratek to Support its NDA Submissions for Omadacycline
news
June 11th, 2014
MMS partners with Wayne State University to place Graduate Students in Scientific Summer Internship Program
webinar
September 26th, 2024
Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance